Phase II clinical trial of parenteral hydroxyurea and hyperfractionated, accelerated external beam radiation therapy in patients with advanced squamous cell carcinoma of the head and neck: Toxicity and efficacy with continuous ribonucleoside reductase inhibition
1979 ◽
Vol 5
(9)
◽
pp. 1531-1535
◽
1999 ◽
Vol 45
(3)
◽
pp. 197
◽
2016 ◽
Vol 30
(3)
◽
pp. 250-256
◽
2014 ◽
Vol 90
(1)
◽
pp. S532-S533
2014 ◽
Vol 90
(1)
◽
pp. S511
1997 ◽
Vol 38
(3)
◽
pp. 507-511
◽
2016 ◽
Vol 96
(2)
◽
pp. E360-E361
2013 ◽
Vol 87
(2)
◽
pp. S160
2015 ◽
Vol 36
(5)
◽
pp. 692-696
◽